Clinical Trial

EMG and Delta Function in Standard RTSA vs Lateralization

Study acronym: EMGRTSA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Reverse total shoulder arthroplasty (RTSA) is a well-established method to treat patients with irreparable rotator cuff tears and glenohumeral osteoarthritis. The biomechanical principle implies a medialization and distalization of the center of rotation (COR). Deficiencies in internal and external rotation constitute frequently encountered functional problems. Some studies showed reduced activation of the posterior deltoid in EMG measurements, which may explain the inability to compensate these movements. Lateralized prosthetic designs demonstrated increased external rotation through an alteration of the deltoid's lever arm. The aim of the study is to investigate the impact of lateralization on functional outcome and deltoid EMG activity in comparison to a standard implantation technique.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-08.
Trial Details
NCT Number NCT07464977
Lead Sponsor Vienna Hospital Association
Conditions Cuff Tear Arthropathy, Omarthrosis, Rotator Cuff Tear Arthropathy
Enrollment 130 participants
Start Date 2026-06
Primary Completion 2027-08 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-07